WithdrawnPHASE1, PHASE2NCT00085449
Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alliance for Clinical Trials in Oncology
- Principal Investigator
- Sherif S. Farag, MD, PhD, FNP-BCIndiana University Melvin and Bren Simon Cancer Center
- Intervention
- alemtuzumab(biological)
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2006 – 2007
Study locations (24)
- Moores UCSD Cancer Center, La Jolla, California, United States
- Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States
- UCSF Comprehensive Cancer Center, San Francisco, California, United States
- CCOP - Christiana Care Health Services, Newark, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C., District of Columbia, United States
- University of Chicago Cancer Research Center, Chicago, Illinois, United States
- Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States
- Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
- University of Minnesota Cancer Center, Minneapolis, Minnesota, United States
- Siteman Cancer Center at Barnes-Jewish Hospital, St Louis, Missouri, United States
- UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States
- St. Joseph's Hospital and Medical Center, Paterson, New Jersey, United States
- Roswell Park Cancer Institute, Buffalo, New York, United States
- Don Monti Comprehensive Cancer Center at North Shore University Hospital, Manhasset, New York, United States
- +9 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00085449 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.